#exercise genetics

A look at how MD Revolution and its technology partners have created the medical practice of the future, today 

The convergence of genomic and digital technology including ingenious wireless sensors, IT systems, data analytics, social networking, the cloud, etc., threaten to revolutionize the way health care is delivered.  One local company, MD Revolution, is making use of these technologies right now to deliver a new model of healthcare for its clients. 

  Working with partners such as Pathway Genomics and Dexcom, MD Revolution is able to tailor care, exercise, treatments, and follow-up for each individual client.  MD Revolution is able to apply unique analytics to the data collected on patients in order to further tailor its recommendations to achieve optimal results.  Come hear from Co-Founder Dr. Damani on how MD Revolution and its partners – Dr. Nova of Pathway Genomics and Dr. Price of Dexcom – are shaking up healthcare and delivering on the promise of tomorrow, today.  Dr. Patrick will also be on hand to help discuss how systematic implementation of preventive care using models such as the MD Revolution prototype will affect healthcare utilization and reduce the cost of chronic disease care.

PANELISTS: Samir Damani, M.D., Pharm.D., F.A.C.C. Co-Founder, Principal & Medical Director, MD Revolution

Samir Damani, M.D., Pharm.D, F.A.C.C. (Fellow of the American College of Cardiology) is a practicing cardiologist and internal medicine physician. He is the Founder of the precision healthcare practice – MD Revolution, which is dedicated to bringing the latest advances in genomic and mobile health technology to the clinical arena.

  Dr. Damani has been a “change agent” in cardiovascular medicine because of his emphasis on more individualized approaches to therapy based on the patient’s genetics, family history, lifestyle, and life goals. Further, he is one of the nation’s few physicians who has advanced training in the pharmaceutical sciences.  In addition to completing a Masters in Clinical Investigation from The Scripps Research Institute, he has directed a National Institutes of Health sponsored study on biomarkers of heart attack. His work has resulted in patent applications for the use of circulating endothelial cells in heart attack, and has spawned collaborations between numerous academic and commercial enterprises including Johnson & Johnson and Scripps Health. His work has been published in top tier peer reviewed scientific journals.

  He has served as a scientific advisor for the prominent journal Science Translational Medicine. He has written over 40 articles and editorial contributions as well as 3 book chapters on the emerging applications of genomic sciences in the last 3 years. He also serves as a reviewer for Nature Genetics, Annals of Internal Medicine, American Journal of Cardiology, and the Journal of the American College of Cardiology, among others.

Michael Nova, M.D. CMO, Pathway Genomics

Dr. Nova is currently the Chief Medical Officer of Pathway Genomics. His scientific career began as a research associate at the Salk Institute in the laboratory of Nobel Laureate Roger Guillemin, where he studied the genetics and proteomics of Human Growth Factors. Michael was the Founder/CEO of Discovery Partners Inc. (Nasdaq: DPII), which completed a successful $150M IPO and marketed wireless drug discovery technology and radiofrequency combinatorial chemistry to large pharmaceutical companies. He then founded the wireless sensory network company Graviton, where he was responsible for raising $60 million in capital from venture groups such as Kleiner Perkins and InQtel and additional. Dr. Nova is also a 2005 World Economic Forum Technology Pioneer Award Winner.

Dr. Nova has over 20 issued and pending patents. He has numerous publications in peer-reviewed journals, and is a Board Certified Dermatopathologist licensed in California. In his minimal spare time, Michael likes to surf big waves in Indonesia, and he helped start a WHO-sanctioned basic care clinic in the Fijian town of Nabila.

David Price, MD Executive Director, Clinical Affairs, DexCom

Dr. Price became executive director of clinical affairs at Dexcom in June 2010.  His many responsibilities at Dexcom include clinical trials, publications, investigator- initiated studies and providing clinical input into new product development.  Prior to joining Dexcom, Dr. Price worked at LifeScan for Johnson and Johnson and was responsible for clinical product development and clinical research.  He has numerous patents and patent applications related to decision support. Dr Price is a diabetologist and held the position of clinical fellow at the Joslin Diabetes Center of New England Deaconess Hospital and Harvard Medical School. He ran a successful clinical practice focused on consultative diabetology for many years in Santa Rosa, California. While in practice, he served as an investigator for numerous pharmaceutical and device trials in diabetes, hypertension, and dyslipidemia.  He is a fellow of the American College of Endocrinology and held a clinical faculty appointment at University of California in San Francisco from 1990-2001. Dr. Price has authored many publications and has lectured on diabetes related topics to physicians, nurses, and the general public across the globe. His internship and residency were completed at the Maine Medical Center, medical degree from the Ohio State University College of Medicine, and undergraduate training at Washington University in St. Louis, Missouri. Dr. Price is from Cleveland, Ohio.  

Kevin Patrick, MD Professor of Family and Preventive Medicine, University of California, San Diego Editor in Chief, American Journal of Preventive Medicine Director of the Center for Wireless and Population Health Systems, Calit2 Kevin Patrick, MD, MS is Professor of Family and Preventive Medicine at the University of California, San Diego, Editor-in-Chief of the American Journal of Preventive Medicine and Director of the Center for Wireless and Population Health Systems at the California Institute for Telecommunications and Information Technology (Calit2), San Diego Division. He is a Senior Advisor to the Robert Wood Johnson Foundation Active Living Research Program and served on the Secretary's Council for Health Promotion and Disease Prevention of the U.S. Department of Health and Human Services and as a member of the Armed Forces Epidemiology Board. He has been a PI or Co-PI on more than $40 million in research and training grants funded by NIH, NSF, CDC, HRSA and others. His present research explores how to use mobile and social technologies to measure and improve health-related behaviors in a variety of populations including overweight adolescents & young adults, English and Spanish-speaking adults with obesity and individuals with chronic disease. He is Co-Founder of Santech, Inc., of San Diego, a company focusing on commercializing evidence-based mobile behavior change technologies.

MODERATOR: Noel Gillespie Partner, Procopio Noel Gillespie is the chair of Procopio's Wireless Health Care and Medical Device Practice Group.  Mr. Gillespie regularly assists clients with strategic patent portfolio development and implementation so as to protect their technology and help them achieve their business objectives. This process includes developing claim strategies that create market barriers and protect or create revenue streams, as well as preparing and prosecuting U.S. and foreign Patent Applications.  Mr. Gillespie has extensive experience in dealing with telecommunications companies, including those involved with wireless, wired, and optical communications technology, medical device companies, semiconductor companies and software/Internet companies. For example, Mr. Gillespie has helped clients build portfolios and protect or build market positions in the areas of wireless sensors for health applications, smart grids, semiconductor memories, lab and chip technology and energy efficient data storage.  In addition to his extensive legal experience, Mr. Gillespie has also served as Senior Design Engineer and Product Team leader for Sony Digital Telecommunications of America in San Diego, where he was responsible for the comprehensive baseband design for several CDMA handsets that used the latest Qualcomm Mobile Station Modem (MSM) chipsets.  He received extensive training in CDMA and wireless communication technology and his design responsibilities fell under the areas of microprocessor circuits, audio circuits, power management circuits, and user interfaces such as keypads and LCDs. Prior to this, he was a Design Engineer and Product Team Leader at Cubic Defense Systems in San Diego, where he was responsible for the design and testing of several portable electronic systems.  Mr. Gillespie successfully managed a team of engineers in the completion of Cubic’s Manworn Laser Detection System, which was part of the MILES 2000 product line, an optical communication system. Mr. Gillespie’s design responsibilities on the product included the areas of optical communications, ASICs, microprocessor circuits, user interfaces, and power management.

SIG CO-CHAIRS: Noel Gillespie, Partner, Procopio Nate Heintzman, Assistant Professor, Divison of Biomedical Informatics, UCSD Don Jones, Vice President, Business Development Health and Life Sciences, Qualcomm Alean Kirnak, President, Software Partners LLC Peter Pardee, VP Business Development, Hughes Network Systems, LLC Alex Robertson, CEO, MediAccess Solutions LLC Paul Sonnier, Wireless Health Group on LinkedIN Ron Richard, Director of Business Development, Qualcomm Wireless Health, Qualcomm Life Carlos Nunez, Chief Medical Officer, CareFusion

DATE: June 19th, 2012

TIME: 5:30PM Registration/Networking/Refreshments 6:00PM Program Begins 7:30PM Program Ends

LOCATION: 12400 High Bluff Drive San Diego, CA 92130

COST:  Pre-Registration: (Please pre-register by noon on 6/18/12) $10.00 - CommNexus Sponsor*** $20.00 - Non-Sponsor FREE - Mentor Sponsor** FREE - Students, Military & Press*

At the Door: $20.00 - CommNexus Sponsor $30.00 - Non-Sponsor FREE - Mentor Sponsor FREE - Students, Military & Press

CLICK HERE for a list of CommNexus Sponsors